Nanobiotix S.A. (NBTX) - יחס שווי שוק לשווי בספרים

The price trend for Nanobiotix S.A. (NBTX) illustrated in this chart is based on the creation of innovative anti-cancer nanoplatforms, where the indicator stands at -44.77. Nanobiotix S.A. (NBTX) implements principles of bioethics and transparent management, strictly adhering to environmental standards for biohazardous waste disposal in its laboratories. It is worth noting that business development is independent of economic cycles, relying exclusively on medical test results.

For Nanobiotix S.A. (NBTX), which is developing innovations in oncology radiotherapy, this ratio determines the market premium over net assets, calculated as the ratio of the total market value of all shares to the book capital. The current value of -44.77 regarding the change in the book capital revaluation level reflects investor expectations concerning the potential of nanoparticles, allowing for an assessment of the company's capitalization stability relative to its actual tangible resources.